xoxosweden.com
Connect
Shrink results results were found for ""
Found in News/Features
Found in Blogs
Found in Forums
Found in Events
Found in Listings
Found in Users
Found in Groups
Found in images

Family / effect size meta analysis ppt

[b][url=http://floodremediation.us/newindex]Replika klokke[/url][/b]
[b][url=http://floodremediation.us/newindex]Billigste rolex klokke[/url][/b]
[b][url=http://floodremediation.us/newindex]Rolex klokker[/url][/b]

Replika klokkeBilligste rolex klokkeRolex klokkerhvem selger de beste replica klokker Replika klokke Billigste rolex klokke Measures of Effect Size of an Intervention | Previous Section | Main Menu | A key question needed to interpret the results of a clinical trial is whether the measured effect size is clinically important yidyfnll. Orologi di marca online a prezzi economici. Three commonly used measures of effect size are relative risk reduction (RRR) , absolute risk reduction (ARR) , and the number needed to treat (NNT) to prevent one bad outcome. These terms are defined below. The material in this section is adapted from Evidence-based medicine: How to practice and teach EBM by DL Sackett, WS Richardson, W Rosenberg and RB Haynes. 1997, New York: Churchill Livingston. Consider the data from the Diabetes Control and Complications Trial (DCCT-Ann Intern Med 1995;122:561-8.). Neuropathy occurred in 9.6% of the usual care group and in 2.8% of the intensively treated group. These rates are sometimes referred to as risks by epidemiologists. For our purposes, risk can be thought of as the rate of some outcome. Relative risk reduction Relative risk measures how much the risk is reduced in the experimental group compared to a control group. For example, if 60% of the control group died and 30% of the treated group died, the treatment would have a relative risk reduction of 0.5 or 50% (the rate of death in the treated group is half of that in the control group). The formula for computing relative risk reduction is: (CER - EER)/CER. CER is the control group event rate and EER is the experimental group event rate. Using the DCCT data, this would work out to (0.096 - 0.028)/0.096 = 0.71 or 71%. This means that neuropathy was reduced by 71% in the intensive treatment group compared with the usual care group. One problem with the relative risk measure is that without knowing the level of risk in the control group, one cannot assess the effect size in the treatment group. Treatments with very large relative risk reductions may have a small effect in conditions where the control group has a very low bad outcome rate. On the other hand, modest relative risk reductions can assume major clinical importance if the baseline (control) rate of bad outcomes is large. Absolute risk reduction Absolute risk reduction is just the absolute difference in outcome rates between the control and treatment groups: CER - EER. The absolute risk reduction does not involve an explicit comparison to the control group as in the relative risk reduction and thus, does not confound the effect size with the baseline risk. However, it is a less intuitve measure to interpret. For the DCCT data, the absolute risk reduction for neuropathy would be (0.096 - 0.028) = 0.068 or 6.8%. This means that for every 100 patients enrolled in the intensive treatment group, about seven bad outcomes would be averted. Number needed to treat The number needed to treat is basically another way to express the absolute risk reduction. It is just 1/ARR and can be thought of as the number of patients that would need to be treated to prevent one additional bad outcome. For the DCCT data, NNT = 1/.068 = 14.7. Thus, for every 15 patients treated with intensive therapy, one case of neuropathy would be prevented. The NNT concept has been gaining in popularity because of its simplicity to compute and its ease of interpretion. NNT data are especially useful in comparing the results of multiple clinical trials in which the relative effectiveness of the treatments are readily apparent. For example, the NNT to prevent stroke by treating patients with very high blood pressures (DBP 115-129) is only 3 but rises to 128 for patients with less severe hypertension (DBP 90-109). | Previous Section | Main Menu | Power and Effect Size. Published by Modified over 2 years ago Embed Download presentation Copy to clipboard Similar presentations More Presentation on theme: "Power and Effect Size."— Presentation transcript: 1 Power and Effect Size 2 Errors Type I Type II Rejecting the Null hypothesis when it is true Failing to reject the Null hypothesis when in fact we should. 3 Errors cont. True State of the World Decision H0 True H0 False Reject H0 Type I error p = α Correct decision p = 1 - β = Power Fail to reject H0 p = 1 - α Type II error p = β 4 Power The probability of rejecting Ho when Ho is false 5 Factors affecting Power Alpha () 6 Factors affecting Power Sample Size 7 Factors affecting Power Variability of dependent scores Statistical test 8 Factors affecting Power The true alternative hypothesis 9 Factors affecting Power Effect Size Extent to which the two distributions do not overlap Cohen 10 11 Effect Size for Matched Samples Example from Howell p 12 Effect Size for Independent Samples 13 Unequal Sample sizes Harmonic mean 14 Power when designing experiments Cohen Optimum level of power - .80 15 Estimating Effect Size based on previous research - can provide a useful estimate. estimated using the method of mimimum meaningful differences, i.e. the smallest difference that will matter, Cohen’s effect size conventions - .2, .5, .8 Meta-analysis 16 Ways of increasing power in a study Download ppt "Power and Effect Size." Ppt on cell structure for class 8 Slides for ppt on it act 2008 Ppt on artificial intelligence in mechanical field Ppt on game theory mario Ppt on structure in c programming Ppt on swine flu free download A ppt on time management Ppt on careers in science Ppt on cloud computing benefits Ppt on email etiquettes presentation church Similar presentations Hypothesis Testing Steps for the Rejection Region Method State H 1 and State H 0 State the Test Statistic and its sampling distribution (normal or t) Determine. Hypothesis Testing. Hypothesis Testing Steps of a Statistical Significance Test. 1. Assumptions Type of data, form of population, method of sampling, sample size. Elementary Statistical Methods André L. Souza, Ph.D. The University of Alabama Lecture 22 Statistical Power. Statistics 101 Class 8. Overview Hypothesis Testing Hypothesis Testing Stating the Research Question Stating the Research Question –Null Hypothesis –Alternative. Chapter 8 Introduction to Hypothesis Testing Copyright © 2013 Pearson Education, Inc. Publishing as Prentice Hall Statistics for Business and Economics 8 th Edition Chapter 9 Hypothesis Testing: Single. Education 793 Class Notes Decisions, Error and Power Presentation 8. HYPOTHESIS TESTING Four Steps Statistical Significance Outcomes Sampling Distributions. Introduction to Hypothesis Testing 1.State your research hypothesis in the form of a relation between two variables. 2. Find a statistic to summarize your sample data and convert the above. Statistical Power The ability to find a difference when one really exists. Business 205. Review Sampling Continuous Random Variables Central Limit Theorem Z-test. Intro to Statistics for the Behavioral Sciences PSYC 1900 Lecture 11: Power. Introduction to hypothesis testing Hypothesis testing is about making decisions Is a hypothesis true or false? Ex. Are women paid less, on average, than. Statistical Significance What is Statistical Significance? What is Statistical Significance? How Do We Know Whether a Result is Statistically Significant? Statistical Significance What is Statistical Significance? How Do We Know Whether a Result is Statistically Significant? How Do We Know Whether a Result. 1 Power and Sample Size in Testing One Mean. 2 Type I & Type II Error Type I Error: reject the null hypothesis when it is true. The probability of a Type. Sampling Distributions Statistics Introduction Let’s assume that the IQ in the population has a mean (  ) of 100 and a standard deviation (  ) Power of a test. power The power of a test (against a specific alternative value) Is In practice, we carry out the test in hope of showing that the null. Similar presentations Presentation is loading. Please wait.... OK Statistics 101 Class 8. Overview Hypothesis Testing Hypothesis Testing Stating the Research Question Stating the Research Question –Null Hypothesis –Alternative. About project SlidePlayer Terms of Service Feedback Privacy Policy Feedback © 2017 SlidePlayer.com Inc. All rights reserved. Search Ads by Google Cohen's h From Wikipedia, the free encyclopedia Jump to: navigation , search In statistics , Cohen's h , popularized by Jacob Cohen , is a measure of distance between two proportions or probabilities . Cohen's h has several related uses: It can be used to describe the difference between two proportions as "small", "medium", or "large". It can be used to determine if the difference between two proportions is " meaningful ". It can be used in calculating the sample size for a future study. When measuring differences between proportions, Cohen's h can be used in conjunction with hypothesis testing . A " statistically significant " difference between two proportions is understood to mean that, given the data, it is likely that there is a difference in the population proportions. However, this difference might be too small to be meaningful—the statistically significant result does not tell us the size of the difference. Cohen's h, on the other hand, quantifies the size of the difference, allowing us to decide if the difference is meaningful. Contents 1 Uses 2 Calculation 3 Interpretation 4 Sample size calculation 5 See also 6 References Uses [ edit ] Researchers have used Cohen's h as follows. Describe the differences in proportions using the rule of thumb criteria set out by Cohen. [1] Namely, h = 0.2 is a "small" difference, h = 0.5 is a "medium" difference, and h = 0.8 is a "large" difference. [2] [3] Only discuss differences that have h greater than some threshold value, such as 0.2. [4] When the sample size is so large that many differences are likely to be statistically significant, Cohen's h identifies "meaningful", " clinically meaningful ", or "practically significant" differences. [4] [5] Calculation [ edit ] Given a probability or proportion p , between 0 and 1, its "arcsine transformation" is ϕ = 2 arcsin ⁡ p {\displaystyle \phi =2\arcsin {\sqrt {p}}} Further information: Binomial proportion confidence interval Given two proportions, p 1 {\displaystyle p_{1}} and p 2 {\displaystyle p_{2}} , h is defined as the difference between their arcsine transformations. [1] Namely, h = ϕ 1 − ϕ 2 {\displaystyle h=\phi _{1}-\phi _{2}} This is also sometimes called "directional h" because, in addition to showing the magnitude of the difference, it shows which of the two proportions is greater. Often, researchers mean "nondirectional h", which is just the absolute value of the directional h: h = | ϕ 1 − ϕ 2 | {\displaystyle h=\left|\phi _{1}-\phi _{2}\right|} In R , Cohen's h can be calculated using the ES.h function in the pwr package. [6] Interpretation [ edit ] Cohen [1] provides the following descriptive interpretations of h as a rule of thumb : h = 0.20: "small effect size". h = 0.50: "medium effect size". h = 0.80: "large effect size". Cohen cautions that: As before, the reader is counseled to avoid the use of these conventions, if he can, in favor of exact values provided by theory or experience in the specific area in which he is working. Nevertheless, many researchers do use these conventions as given. Sample size calculation [ edit ] This section is empty. You can help by adding to it . (June 2015) See also [ edit ] Statistics portal Estimation statistics Clinical significance Cohen's d Odds ratio Effect size Sample size determination References [ edit ] ^ a b c Cohen, Jacob (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.).   ^ Yu, Xiaonan; et al. (2012). "The Patient Health Questionnaire-9 for measuring depressive symptoms among the general population in Hong Kong". Comprehensive Psychiatry . 53 : 95–102. doi : 10.1016/j.comppsych.2010.11.002 .   ^ Titus, Janet C.; et al. (February 2008). "Characteristics of Youths With Hearing Loss Admitted to Substance Abuse Treatment". Journal of Deaf Studies and Deaf Education . 13 : 336–350. doi : 10.1093/deafed/enm068 .   ^ a b Reavley, Nicola J.; et al. (2012). "Stigmatising attitudes towards people with mental disorders: Changes in Australia over 8 years". Psychiatry Research . 197 : 302–306. doi : 10.1016/j.psychres.2012.01.011 .   ^ Yap, Marie Bee Hui; et al. (2012). "Intentions and helpfulness beliefs about first aid responses for young people with mental disorders: Findings from two Australian national surveys of youth". Journal of Affective Disorders . 136 : 430–442. PMID   22137764 . doi : 10.1016/j.jad.2011.11.006 .   ^ Champely, Stephane (2015). "pwr: Basic Functions for Power Analysis" .   v t e Clinical research and experimental design Overview Clinical trial Trial protocols Adaptive clinical trial Academic clinical trials Clinical study design Controlled study ( EBM I to II-1; A to B ) Randomized controlled trial Scientific experiment Blind experiment Open-label trial Observational study ( EBM II-2 to II-3; B to C ) Cross-sectional study vs. Longitudinal study , Ecological study Cohort study Retrospective Prospective Case-control study ( Nested case-control study ) Case series Case study Case report Epidemiology / methods occurrence : Incidence ( Cumulative incidence ) Prevalence Point Period association : absolute ( Absolute risk reduction , Attributable risk , Attributable risk percent ) relative ( Relative risk , Odds ratio , Hazard ratio ) other : Clinical endpoint Virulence Infectivity Mortality rate Morbidity Case fatality rate Specificity and sensitivity Likelihood-ratios Pre/post-test probability Trial/test types In vitro In vivo Animal testing Animal testing on non-human primates First-in-man study Multicenter trial Seeding trial Vaccine trial Analysis of clinical trials Risk–benefit ratio Systematic review Replication Meta-analysis Intention-to-treat analysis Interpretation of results Selection bias Survivorship bias Correlation does not imply causation Null result Category Glossary List of topics v t e Statistics Outline Index Descriptive statistics Continuous data Center Mean arithmetic geometric harmonic Median Mode Dispersion Variance Standard deviation Coefficient of variation Percentile Range Interquartile range Shape Moments Skewness Kurtosis L-moments Count data Index of dispersion Summary tables Grouped data Frequency distribution Contingency table Dependence Pearson product-moment correlation Rank correlation Spearman's rho Kendall's tau Partial correlation Scatter plot Graphics Bar chart Biplot Box plot Control chart Correlogram Fan chart Forest plot Histogram Pie chart Q–Q plot Run chart Scatter plot Stem-and-leaf display Radar chart Data collection Study design Population Statistic Effect size Statistical power Sample size determination Missing data Survey methodology Sampling stratified cluster Standard error Opinion poll Questionnaire Controlled experiments Design control optimal Controlled trial Randomized Random assignment Replication Blocking Interaction Factorial experiment Uncontrolled studies Observational study Natural experiment Quasi-experiment Statistical inference Statistical theory Population Statistic Probability distribution Sampling distribution Order statistic Empirical distribution Density estimation Statistical model L p space Parameter location scale shape Parametric family Likelihood   (monotone) Location–scale family Exponential family Completeness Sufficiency Statistical functional Bootstrap U V Optimal decision loss function Efficiency Statistical distance divergence Asymptotics Robustness Frequentist inference Point estimation Estimating equations Maximum likelihood Method of moments M-estimator Minimum distance Unbiased estimators Mean-unbiased minimum-variance Rao–Blackwellization Lehmann–Scheffé theorem Median unbiased Plug-in Interval estimation Confidence interval Pivot Likelihood interval Prediction interval Tolerance interval Resampling Bootstrap Jackknife Testing hypotheses 1- & 2-tails Power Uniformly most powerful test Permutation test Randomization test Multiple comparisons Parametric tests Likelihood-ratio Wald Score Specific tests Z (normal) Student's t -test F Goodness of fit Chi-squared Kolmogorov–Smirnov Anderson–Darling Normality (Shapiro–Wilk) Likelihood-ratio test Model selection Cross validation AIC BIC Rank statistics Sign Sample median Signed rank (Wilcoxon) Hodges–Lehmann estimator Rank sum (Mann–Whitney) Nonparametric anova 1-way (Kruskal–Wallis) 2-way (Friedman) Ordered alternative (Jonckheere–Terpstra) Bayesian inference Bayesian probability prior posterior Credible interval Bayes factor Bayesian estimator Maximum posterior estimator Correlation Regression analysis Correlation Pearson product-moment Partial correlation Confounding variable Coefficient of determination Regression analysis Errors and residuals Regression model validation Mixed effects models Simultaneous equations models Multivariate adaptive regression splines (MARS) Linear regression Simple linear regression Ordinary least squares General linear model Bayesian regression Non-standard predictors Nonlinear regression Nonparametric Semiparametric Isotonic Robust Heteroscedasticity Homoscedasticity Generalized linear model Exponential families Logistic (Bernoulli)  / Binomial  / Poisson regressions Partition of variance Analysis of variance (ANOVA, anova) Analysis of covariance Multivariate ANOVA Degrees of freedom Categorical  / Multivariate  / Time-series  / Survival analysis Categorical Cohen's kappa Contingency table Graphical model Log-linear model McNemar's test Multivariate Regression Anova Principal components Canonical correlation Discriminant analysis Cluster analysis Classification Structural equation model Factor analysis Multivariate distributions Elliptical distributions Normal Time-series General Decomposition Trend Stationarity Seasonal adjustment Exponential smoothing Cointegration Structural break Granger causality Specific tests Dickey–Fuller Johansen Q-statistic (Ljung–Box) Durbin–Watson Breusch–Godfrey Time domain Autocorrelation (ACF) partial (PACF) Cross-correlation (XCF) ARMA model ARIMA model (Box–Jenkins) Autoregressive conditional heteroskedasticity (ARCH) Vector autoregression (VAR) Frequency domain Spectral density estimation Fourier analysis Wavelet Survival Survival function Kaplan–Meier estimator (product limit) Proportional hazards models Accelerated failure time (AFT) model First hitting time Hazard function Nelson–Aalen estimator Test Log-rank test Applications Biostatistics Bioinformatics Clinical trials  / studies Epidemiology Medical statistics Engineering statistics Chemometrics Methods engineering Probabilistic design Process  / quality control Reliability System identification Social statistics Actuarial science Census Crime statistics Demography Econometrics National accounts Official statistics Population statistics Psychometrics Spatial statistics Cartography Environmental statistics Geographic information system Geostatistics Kriging Category Portal Commons WikiProject v t e Design of experiments Scientific method Scientific experiment Statistical design Control Internal and external validity Experimental unit Blinding Optimal design : Bayesian Random assignment Randomization Restricted randomization Replication versus subsampling Sample size Treatment and blocking Treatment Effect size Contrast Interaction Confounding Orthogonality Blocking Covariate Nuisance variable Models and inference Linear regression Ordinary least squares Bayesian Random effect Mixed model Hierarchical model: Bayesian Analysis of variance (Anova) Cochran's theorem Manova ( multivariate ) Ancova ( covariance ) Compare means Multiple comparison Designs Completely randomized Factorial Fractional factorial Plackett-Burman Taguchi Response surface methodology Polynomial and rational modeling Box-Behnken Central composite Block Generalized randomized block design (GRBD) Latin square Graeco-Latin square Orthogonal array Latin hypercube Repeated measures design Crossover study Randomized controlled trial Sequential analysis Sequential probability ratio test Glossary Category Statistics portal Statistical outline Statistical topics Retrieved from " https://en./w/index.php?title=Cohen%27s_h&oldid=766379987 " Categories : Effect size Statistical hypothesis testing Medical statistics Clinical research Clinical trials Biostatistics Sampling (statistics) Hidden categories: Articles to be expanded from June 2015 All articles to be expanded Articles with empty sections from June 2015 All articles with empty sections Articles using small message boxes توقيت جرينتش الان بالمغرب cheap replica watches uk Dyreste rolex Rolex スイス 時計 安い stylo dupont argent massif

0 Comments

Bookmark and Share